tradingkey.logo

BGM Group Ltd

BGM
View Detailed Chart
9.635USD
+0.175+1.85%
Close 11/03, 16:00ETQuotes delayed by 15 min
947.07MMarket Cap
--P/E TTM

BGM Group Ltd

9.635
+0.175+1.85%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.85%

5 Days

+3.05%

1 Month

+0.68%

6 Months

-17.65%

Year to Date

+14.02%

1 Year

+34.76%

View Detailed Chart

TradingKey Stock Score of BGM Group Ltd

Currency: USD Updated: 2025-10-27

Key Insights

Its valuation is considered undervalued,and institutional recognition is very low. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

BGM Group Ltd's Score

Industry at a Glance

Industry Ranking
138 / 173
Overall Ranking
593 / 4682
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

BGM Group Ltd Highlights

StrengthsRisks
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Growing
The company is in a growing phase, with the latest annual income totaling USD 25.10M.
Overvalued
The company’s latest PE is -32.82, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 132.27K shares, increasing 18.83% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 29.97K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

BGM Group Ltd Info

BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Ticker SymbolBGM
CompanyBGM Group Ltd
CEOMr. Zhanchang Xin
Websitehttps://www.bgmgroupltd.com/
KeyAI